- 2024-08-20 01:54抑制剂EN4|EN4|1197824-15-9|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂Emapunil|Emapunil|226954-04-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂Emapunil|Emapunil|226954-04-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂Emavusertib|Emavusertib|1801344-14-8|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:54抑制剂EMAC10101d|EMAC10101d|2561476-24-0|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:54抑制剂EMAC10101d|EMAC10101d|2561476-24-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂EMAC10101d|EMAC10101d|2561476-24-0|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂Emapunil|Emapunil|226954-04-7|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:54抑制剂Elzovantinib|Elzovantinib|2271119-26-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂Elzovantinib|Elzovantinib|2271119-26-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂Elamipretide|Elamipretide|736992-21-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂Elamipretide|Elamipretide|736992-21-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂Elzovantinib|Elzovantinib|2271119-26-5|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:54抑制剂Elacridar hydrochloride|Elacridar hydrochloride|143851-98-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂Elamipretide|Elamipretide|736992-21-5|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:54抑制剂EJMC-1|EJMC-1|397281-20-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂Elacridar hydrochloride|Elacridar hydrochloride|143851-98-3|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:54抑制剂Elacridar hydrochloride|Elacridar hydrochloride|143851-98-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂EIPA|EIPA|1154-25-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂EIPA|EIPA|1154-25-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
